Clinical Trials Browser

Lymphoma × patritumab × Clear all

NCT01479023 2013-12-20

Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors

Phase 1 Terminated

LymphoidSarcoma

Carcinoma, Lymphoma, Sarcoma